Brain Substrate Switch to Ketones and Lactate
BSS
Does Cerebral Substrate Switching Underlie the Beneficial Brain Adaptations of Fasting and Exercise?
1 other identifier
interventional
12
1 country
1
Brief Summary
The brain is constantly active and energetically expensive, making up a quarter of the body's energy budget despite occupying only 2% of its mass. To fuel this incessant activity, the brain relies on glucose, which accommodates 99% of its metabolic needs. In most cases, glucose is the ideal fuel since it is in constant surplus owing to 24-hr access to sugar-rich food. However, the brain is metabolically flexible and capable of metabolizing alternative fuels when glucose is scarce, or, decreasing rapidly. For example, during fasting when glucose stores are dwindling, ketone bodies can supplement the brain's metabolic needs. During intense exercise, when glucose stores are being rapidly depleted, lactate - a byproduct of this glucose turnover - similarly acts as an alternative fuel for the brain. In healthy individuals, exploiting this 'brain metabolic flexibility' may be beneficial in protecting the brain from aging. The main question is: Does the brain substrate switch that occurs during fasting and high-intensity exercise underlie the beneficial effects on the brain? Young, healthy participants will fast for 3 days and complete high-intensity cycling exercise, each of which will induce a brain substrate switch. Participants will also be passively infused with ketones (to simulate fasting) and lactate (to simulate high-intensity exercise) in the fed and rested state. In doing so, the investigators will isolate the brain substrate switch from the broader, pluripotent stressors that encompass fasting and exercise. The main outcome variables are the brain biomarkers: brain-derived neurotrophic factor (BDNF) and secreted amyloid beta precursor protein (sAPPA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedAugust 24, 2023
August 1, 2023
3 months
August 14, 2023
August 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain-derived neurotrophic factor, secreted amyloid beta precursor protein
Biomarker to index neuroplasticity and resilience
Data collected at rest, during graded infusions of lactate and ketones, pre- and post- 6 minutes of high-intensity cycling exercise
Secondary Outcomes (1)
Brain substrate metabolism
Data collected at rest, during graded infusions of lactate and ketones, pre- and post- 6 minutes of high-intensity cycling exercise
Study Arms (2)
Fed
ACTIVE COMPARATORExercise and passive infusions of ketones and lactate in the fed state. Participants will be fed a small meal in the middle of the protocol, also.
Fasted
EXPERIMENTALExercise and passive infusions of ketones and lactate in the fasted state. Participants will be required to fast for 72 hours prior to arriving to the lab for this testing arm.
Interventions
Eligibility Criteria
You may qualify if:
- Regularly physically active, as determined via questionnaires
You may not qualify if:
- Current smokers
- Acute bronchial asthma, chronic obstructive airway or status asthmaticus
- Obese (body mass index greater than 30 kg m-2)
- Requiring daily prescription medications that may affect responses to exercise, e.g., anti-hypertensives, anti-arrhythmogenics, inhalers
- History of disease/dysfunction that could cause complication with exercise, e.g. cardiovascular, respiratory, neurological or musculoskeletal diseases
- Irregular or absent menstrual cycle (females)
- Pregnant or may suspect pregnancy, or post-menopausal (females)
- Any unexpected adverse responses to pre-experimental exercise tests
- Any contraindication to a lumbar subarachnoid access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- University of Otagocollaborator
Study Sites (1)
University of British Columbia - Okanagan Campus
Kelowna, British Columbia, V1V1V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The participant will not be blinded because they must consciously adhere to study requirements, i.e., fasting for 3 days. The investigators will be blinded to the fasting and fed conditions.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 14, 2023
First Posted
August 21, 2023
Study Start
October 1, 2023
Primary Completion
January 1, 2024
Study Completion
January 1, 2024
Last Updated
August 24, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
No personal data will be made available publicly or to other researchers.